“Adverse reactions due to monoclonal antibodies in the treatment of allergic diseases. Group Positioning: Comité de Alergia a Medicamentos del Colegio Mexicano de Inmunología Clínica y Alergia (CMICA 2024-2025)”., Rev Alerg Mex, vol. 72, no. 1, pp. 52–71, Mar. 2025, doi: 10.29262/fsaxnm03.